311 related articles for article (PubMed ID: 27235684)
1. Advances in PET Detection of the Antitumor T Cell Response.
McCracken MN; Tavaré R; Witte ON; Wu AM
Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
[TBL] [Abstract][Full Text] [Related]
2. In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET.
Yusufi N; Mall S; Bianchi HO; Steiger K; Reder S; Klar R; Audehm S; Mustafa M; Nekolla S; Peschel C; Schwaiger M; Krackhardt AM; D'Alessandria C
Theranostics; 2017; 7(9):2402-2416. PubMed ID: 28744323
[TBL] [Abstract][Full Text] [Related]
3. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes.
Moroz MA; Zanzonico P; Lee JT; Ponomarev V
Methods Mol Biol; 2018; 1790():153-163. PubMed ID: 29858790
[TBL] [Abstract][Full Text] [Related]
6. Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET.
Matsui K; Wang Z; McCarthy TJ; Allen PM; Reichert DE
Nucl Med Biol; 2004 Nov; 31(8):1021-31. PubMed ID: 15607484
[TBL] [Abstract][Full Text] [Related]
7. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts.
Perez C; Jukica A; Listopad JJ; Anders K; Kühl AA; Loddenkemper C; Blankenstein T; Charo J
Int J Cancer; 2015 Jul; 137(2):359-71. PubMed ID: 25530110
[TBL] [Abstract][Full Text] [Related]
8. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
Tavaré R; Escuin-Ordinas H; Mok S; McCracken MN; Zettlitz KA; Salazar FB; Witte ON; Ribas A; Wu AM
Cancer Res; 2016 Jan; 76(1):73-82. PubMed ID: 26573799
[TBL] [Abstract][Full Text] [Related]
9. Adoptive T-cell therapy of cancer.
Yee C
Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731
[TBL] [Abstract][Full Text] [Related]
10. Genetic redirection of T cells for cancer therapy.
Westwood JA; Kershaw MH
J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
[TBL] [Abstract][Full Text] [Related]
11. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
Tavaré R; McCracken MN; Zettlitz KA; Salazar FB; Olafsen T; Witte ON; Wu AM
J Nucl Med; 2015 Aug; 56(8):1258-64. PubMed ID: 25952734
[TBL] [Abstract][Full Text] [Related]
12. Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes.
Lee JT; Moroz MA; Ponomarev V
Methods Mol Biol; 2018; 1790():165-180. PubMed ID: 29858791
[TBL] [Abstract][Full Text] [Related]
13. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease.
Thomas AK; June CH
Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267
[TBL] [Abstract][Full Text] [Related]
14. Antigen choice in adoptive T-cell therapy of cancer.
Offringa R
Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of cancer immunotherapy.
Tumeh PC; Radu CG; Ribas A
J Nucl Med; 2008 Jun; 49(6):865-8. PubMed ID: 18511842
[TBL] [Abstract][Full Text] [Related]
16. Preclinical development of T cell receptor gene therapy.
Bendle GM; Haanen JB; Schumacher TN
Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.
Nesbeth Y; Conejo-Garcia JR
Clin Dev Immunol; 2010; 2010():139304. PubMed ID: 21076522
[TBL] [Abstract][Full Text] [Related]
18. Optimizing T-cell expansion: have we reached the limit?
Melenhorst JJ
Cytotherapy; 2009; 11(7):813-4. PubMed ID: 19903094
[No Abstract] [Full Text] [Related]
19. In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.
Pittet MJ; Grimm J; Berger CR; Tamura T; Wojtkiewicz G; Nahrendorf M; Romero P; Swirski FK; Weissleder R
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12457-61. PubMed ID: 17640914
[TBL] [Abstract][Full Text] [Related]
20. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]